News of Note—Pfizer results, GSK shortage and more

In this week's news of note, Pfizer's Prevnar posted a third-quarter sales increase due to government purchases. (Pixabay)

Here is some other vaccine news of note for the week:

> Pfizer's vaccine sales in the third quarter grew 12% to $1.85 billion. Prevnar 13 sales in the U.S. were up 12% due to the timing of government purchases. Release (PDF)

> Pharmacists in Canada are reporting a shortage of GlaxoSmithKline's hep A and B vaccine for travelers Twinrix. CBC article


Veeva 2019 Unified Clinical Operations Survey

Share your thoughts in this quick survey. The first 50 qualified respondents will receive a $5 Amazon gift card, and, in appreciation for your time, all qualified survey respondents will be entered in a drawing to win a $50 Amazon gift card.

> A subsidiary of South Korea's GC Pharma received approval to start phase 1 testing of a shingles vaccine. Release

> Enesi Pharma entered an R&D deal to work on vaccines against Chikungunya, Zika and peanut allergy. Release